Analysis of motor function in 6-month-old male and female 3xTg-AD mice

Behavioural Brain Research

Volumn 281, Issue , 2015, Pages 16-23

  Stover, Kurt R ^a   Campbell, Mackenzie A ^a   Van Winssen, Christine M ^a   Brown, Richard E ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

3xTg AD; Alzheimer's disease; Motor Behaviour; Mouse Model

Indexed keywords

3XTG MOUSE; ANIMAL EXPERIMENT; ARTICLE; BODY EQUILIBRIUM; BODY WEIGHT; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; GAIT; GENOTYPE; GRIP STRENGTH; LATENT PERIOD; MALE; MOTOR COORDINATION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PHENOTYPE; ROTAROD TEST; RUNNING; SEX DIFFERENCE; WILD TYPE; 129 MOUSE; ALZHEIMER DISEASE; ANIMAL; DISEASE MODEL; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; FEMALE; GAIT; MALE; MICE; MICE, 129 STRAIN; MICE, TRANSGENIC; MOTOR ACTIVITY; ROTAROD PERFORMANCE TEST;

EID: 84920903251     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.11.046     Document Type: Article

References (47)

1. Chin J. Selecting a mouse model of Alzheimer's disease. Methods Mol Biol (Clifton, NJ) 2011, 67. 10.1007/978-1-60761-744-0.
2. LaFerla F.M., Green K.N. Animal models of Alzheimer disease. Cold Spring Harb Perspect Med 2012, 2:a006320. 10.1101/cshperspect.a006320.
3. Webster S.J., Bachstetter A.D., Nelson P.T., Schmitt F.A., Van Eldik L.J. Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet 2014, 5:88. 10.3389/fgene.2014.00088.
4. Bilkei-Gorzo A. Genetic mouse models of brain ageing and Alzheimer's disease. Pharmacol Ther 2014, 142:244-257. 10.1016/j.pharmthera.2013.12.009.
5. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 2003, 39:409-421.
6. Billings L.M., Oddo S., Green K.N., McGaugh J.L., LaFerla F.M. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005, 45:675-688. 10.1016/j.neuron.2005.01.040.
7. Mastrangelo M.A., Bowers W.J. Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice. BMC Neurosci 2008, 9:81. 10.1186/1471-2202-9-81.
8. Desai M.K., Sudol K.L., Janelsins M.C., Mastrangelo M.A., Frazer M.E., Bowers W.J. Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology. Glia 2009, 57:54-65. 10.1002/glia.20734.
9. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939. 10.1212/WNL.34.7.939.
10. Carrillo M.C., Dean R.A., Nicolas F., Miller D.S., Berman R., Khachaturian Z., et al. Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria. Alzheimers Dement 2013, 9:594-601. 10.1016/j.jalz.2013.05.1762.
11. Kluger A., Gianutsos J.G., Golomb J., Ferris S.H., Reisberg B. Motor/psychomotor dysfunction in normal aging, mild cognitive decline, and early Alzheimers disease: diagnostic and differential diagnostic features. Int Psychogeriatr 1997, 9:307-316. 10.1017/S1041610297005048.
12. Pettersson A.F., Olsson E., Wahlund L.-O. Motor function in subjects with mild cognitive impairment and early Alzheimer's disease. Dement Geriatr Cogn Disord 2005, 19:299-304. 10.1159/000084555.
13. Dick M.B., Nielson K.A., Beth R.E., Shankle W.R., Cotman C.W. Acquisition and long-term retention of a fine motor skill in Alzheimer's disease. Brain Cogn 1995, 29:294-306. 10.1006/brcg.1995.1283.
14. Eslinger P.J., Damasio A.R. Preserved motor learning in Alzheimer's disease: implications for anatomy and behavior. J Neurosci 1986, 6:3006-3009.
15. Buchman A.S., Bennett D.A. Loss of motor function in preclinical Alzheimer's disease. Expert Rev Neurother 2011, 11:665-676. 10.1586/ern.11.57.
16. Albers M.W., Gilmore G.C., Kaye J., Murphy C., Wingfield A., Bennett D.A., et al. At the interface of sensory and motor dysfunctions and Alzheimer's disease. Alzheimers Dement 2014, 1-29. 10.1016/j.jalz.2014.04.514.
17. Gras L.Z., Kanaan S.F., McDowd J.M., Colgrove Y.M., Burns J., Pohl P.S. Balance and gait of adults with very mild Alzheimer disease. J Geriatr Phys Ther 2014, 10.1519/JPT.0000000000000020.
18. Reuben D.B., Magasi S., McCreath H.E., Bohannon R.W., Wang Y.-C., Bubela D.J., et al. Motor assessment using the NIH Toolbox. Neurology 2013, 80:S65-S75. 10.1212/WNL.0b013e3182872e01.
19. Brooks S.P., Dunnett S.B. Tests to assess motor phenotype in mice: a user's guide. Nat Rev Neurosci 2009, 10:519-529. 10.1038/nrn2652.
20. Justice J.N., Carter C.S., Beck H.J., Gioscia-Ryan R.A., McQueen M., Enoka R.M., et al. Battery of behavioral tests in mice that models age-associated changes in human motor function. Age (Omaha) 2014, 36:583-592. 10.1007/s11357-013-9589-9.
21. Blanchard J., Wanka L., Tung Y.-C., Cárdenas-Aguayo M., del C., LaFerla F.M., et al. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice. Acta Neuropathol 2010, 120:605-621. 10.1007/s00401-010-0734-6.
22. Chen Y., Liang Z., Blanchard J., Dai C.-L., Sun S., Lee M.H., et al. A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse). Mol Neurobiol 2013, 47:711-725. 10.1007/s12035-012-8375-5.
23. Billings L.M., Green K.N., McGaugh J.L., LaFerla F.M. Learning decreases A beta*56 and tau pathology and ameliorates behavioral decline in 3xTg-AD mice. J Neurosci 2007, 27:751-761. 10.1523/JNEUROSCI.4800-06.2007.
24. España J., Giménez-Llort L., Valero J., Miñano A., Rábano A., Rodriguez-Alvarez J., et al. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice. Biol Psychiatry 2010, 67:513-521. 10.1016/j.biopsych.2009.06.015.
25. Clinton L.K., Billings L.M., Green K.N., Caccamo A., Ngo J., Oddo S., et al. Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol Dis 2007, 28:76-82. 10.1016/j.nbd.2007.06.013.
26. Oore J.J., Fraser L.M., Brown R.E. Age-related changes in motor ability and motor learning in triple transgenic (3xTg-AD) and control (B6129SF1/J) mice on the accelerating Rotarod. Proc Nov Scotian Inst Sci 2013, 74:281-296.
27. Blaney C.E., Gunn R.K., Stover K.R., Brown R.E. Maternal genotype influences behavioral development of 3xTg-AD mouse pups. Behav Brain Res 2013, 252:40-48. 10.1016/j.bbr.2013.05.033.
28. Filali M., Lalonde R., Theriault P., Julien C., Calon F., Planel E. Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD). Behav Brain Res 2012, 234:334-342. 10.1016/j.bbr.2012.07.004.
29. Sterniczuk R., Antle M.C., Laferla F.M., Dyck R.H. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes. Brain Res 2010, 1348:149-155. 10.1016/j.brainres.2010.06.011.
30. Arsenault D., Julien C., Tremblay C., Calon F. DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice. PLoS ONE 2011, 6:e17397. 10.1371/journal.pone.0017397.
31. García-Mesa Y., López-Ramos J.C., Giménez-Llort L., Revilla S., Guerra R., Gruart A., et al. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice. J Alzheimers Dis 2011, 24:421-454. 10.3233/JAD-2011-101635.
32. Sterniczuk R., Dyck R.H., Laferla F.M., Antle M.C. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1, circadian changes. Brain Res 2010, 1348:139-148. 10.1016/j.brainres.2010.05.013.
33. Brown R.E., Wong A.A. The influence of visual ability on learning and memory performance in 13 strains of mice. Learn Mem 2007, 14:134. 10.1101/lm.473907.
34. Fleming S.M., Salcedo J., Fernagut P., Rockenstein E., Masliah E., Levine M.S., et al. Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. J Neurosci 2004, 24:9434-9440. 10.1523/JNEUROSCI.3080-04.2004.
35. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 1999, 19:3248-3257.
36. Wright S.L., Brown R.E. The importance of paternal care on pup survival and pup growth in Peromyscus californicus when required to work for food. Behav Process 2002, 60:41-52.
37. Akaike H. A new look at the statistical model identification. Autom Control IEEE Trans 1974, 19:716-723.
38. Burnham K.P., Anderson D.R. Model selection and multimodel inference a practical information: theoretic approach 2002, Springer Science & Business Media, New York. 2nd ed.
39. Hedges L.V. Distribution theory for glass's estimator of effect size and related estimators. J Educ Behav Stat 1981, 6:107-128. 10.3102/10769986006002107.
40. Cumming G. The new statistics: why and how. Psychol Sci 2014, 25:7-29. 10.1177/0956797613504966.
41. Morgan D., Munireddy S., Alamed J., DeLeon J., Diamond D.M., Bickford P., et al. Apparent behavioral benefits of tau overexpression in P301L tau transgenic mice. J Alzheimers Dis 2008, 15:605-614.
42. Peters O.M., Shelkovnikova T., Tarasova T., Springe S., Kukharsky M.S., Smith G.A., et al. Chronic administration of Dimebon does not ameliorate amyloid-β pathology in 5xFAD transgenic mice. J Alzheimers Dis 2013, 36:589-596. 10.3233/JAD-130071.
43. Héraud C., Goufak D., Ando K., Leroy K., Suain V., Yilmaz Z., et al. Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice. Neurobiol Dis 2014, 62:100-112. 10.1016/j.nbd.2013.09.010.
44. Kuwabara Y., Ishizeki M., Watamura N., Toba J., Yoshii A., Inoue T., et al. Impairments of long-term depression induction and motor coordination precede Aβ accumulation in the cerebellum of APPswe/PS1dE9 double transgenic mice. J Neurochem 2014, 130:432-443. 10.1111/jnc.12728.
45. Boekhoorn K., Terwel D., Biemans B., Borghgraef P., Wiegert O., Ramakers G.J.A., et al. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy. J Neurosci 2006, 26:3514-3523. 10.1523/JNEUROSCI.5425-05.2006.
46. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., Van Slegtenhorst M., et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 2000, 25:402-405. 10.1038/78078.
47. Cedervall Y., Halvorsen K., Aberg A.C. A longitudinal study of gait function and characteristics of gait disturbance in individuals with Alzheimer's disease. Gait Posture 2014, 39:1022-1027. 10.1016/j.gaitpost.2013.12.026.